Evidence map›Paper›PMID 26936259›Full record

ReviewCurrent neurology and neuroscience reports2016

A Review and Update on Tourette Syndrome: Where Is the Field Headed?

Aysegul Gunduz, Michael S Okun

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Current neurology and neuroscience reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06889480 (MultitArget STereotactic Electrophysiological Recording and Stimulation for Tourette Syndrome), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
6.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06889480 narecruitingnot on this mapstarted 2024, after this paper: background citation

MultitArget STereotactic Electrophysiological Recording and Stimulation for Tourette Syndrome

TypeinterventionalSponsorBeijing Tiantan HospitalRan2024 to 2026Enrolled5ConditionsTourette Syndrome, Deep Brain StimulationArmsNew Target DBS, CM-DBS, Sham Stimulation
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Architecture of the subthalamic nucleus.Communications biology · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Tourette Syndrome: A Mini-Review.Frontiers in neurology · 2018
    Review
  10. Article
  11. Article
  12. Deutetrabenazine in Tics Associated with Tourette Syndrome.Tremor and other hyperkinetic movements (New York, N.Y.) · 2016
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Aysegul GunduzJ. Crayton Pruitt Family Department of Biomedical Engineering, Gainesville, FL, USA.
Michael S OkunUF Health Center for Movement Disorders and Neurorestoration, Gainesville, FL, USA. okun@neurology.ufl.edu.
University of Florida Health · US

Funding

Scheduled and Responsive Brain Stimulation for the Treatment of Tourette SyndromeR34MH080764 · NIMH · UNIVERSITY OF FLORIDA · PI OKUN, MICHAEL S · 2008 to 2010
$617k
Neural Correlates of Tourette SyndromeR21NS072897 · NINDS · UNIVERSITY OF MIAMI CORAL GABLES · PI OKUN, MICHAEL S, PRASAD, ABHISHEK · 2010 to 2011
$448k
NIMH NIH HHS R34MH080764NINDS NIH HHS R211NS072897
6 · The paper itself

Abstract

Tourette syndrome (TS) is a childhood onset neurologic disorder with manifestations including multiple motor and phonic tics, and in most cases a variety of behavioral comorbidities such as attention deficit hyperactivity disorder, obsessive compulsive disorder, and other impulse control disorders. Although it is considered a hereditary disorder, likely modified by environmental factors, genetic studies have yet to uncover relevant causative genes and there is no animal model that mimics the broad clinical phenomenology of TS. There has been a marked increase in the number of neurophysiological, neuroimaging, and other studies on TS. The findings from these studies, however, have been difficult to interpret because of small sample sizes, variability of symptoms across patients, and comorbidities. Although anti-dopaminergic drugs are the most widely used medications in the treatment of TS, there has been increasing interest in other drugs, behavioral therapies, and surgical approaches including deep brain stimulation. Herein, we review the current literature and discuss the complexities of TS and the challenges in understanding its pathophysiology and in selecting the most appropriate treatment. We also offer an expert's view of where the field of TS may be headed.

Indexed as

Tourette SyndromeAnimalsComorbidityHumansNeuroimagingMovement disordersNeurodevelopmental disordersTic disordersTourette syndrome

Identifiers

PMID26936259
OpenAlexW2294027246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.